Ras inhibition amplifies cisplatin sensitivity of human glioblastoma

Samantha Messina, Carlo Leonetti, Giorgia De Gregorio, Valentina Affatigato, Giuseppe Ragona, Luigi Frati, Gabriella Zupi, Angela Santoni, Antonio Porcellini

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Resistance to chemotherapy is a common feature of malignant gliomas. This resistance is mediated by receptor tyrosine kinase (RTK)-regulated signaling. p21-Ras protein is pivotal in the propagation of the signal originated from many RTKs. Our aim was to investigate whether inhibition of Ras pathway affects the response to cisplatin in malignant gliomas. We found an enhanced sensitivity to cisplatin of two glioblastoma cell lines expressing dominant negative Ras. Moreover, DN-Ras expressing cells, implanted in nude mice, resulted in being extremely sensitive to cisplatin. The growth of all the tumors was significantly inhibited by combining DN-Ras adenovirus infection with cisplatin treatment. The majority of glioma cells expressing DN-Ras underwent apoptosis in response to cisplatin. In vivo, DN-Ras alone did not influence the growth of tumors, suggesting that the effects of Ras-inhibition observed in vitro could not be extrapolated in vivo. The survival signal pathway transduced by Ras was essentially mediated by inhibition of caspase-9 cleavage via PI3K/Akt.

Original languageEnglish
Pages (from-to)493-500
Number of pages8
JournalBiochemical and Biophysical Research Communications
Volume320
Issue number2
DOIs
Publication statusPublished - Jul 23 2004

Fingerprint

Glioblastoma
Cisplatin
Glioma
Tumors
Cells
Proto-Oncogene Proteins p21(ras)
Adenoviridae Infections
ras Proteins
Chemotherapy
Caspase 9
Receptor Protein-Tyrosine Kinases
Growth
Phosphatidylinositol 3-Kinases
Nude Mice
Signal Transduction
Neoplasms
Apoptosis
Drug Therapy
Cell Line
Survival

Keywords

  • Apoptosis
  • Chemotherapy
  • Drug resistance
  • Gene therapy
  • Glioblastoma
  • Ras
  • Signal transduction

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Ras inhibition amplifies cisplatin sensitivity of human glioblastoma. / Messina, Samantha; Leonetti, Carlo; De Gregorio, Giorgia; Affatigato, Valentina; Ragona, Giuseppe; Frati, Luigi; Zupi, Gabriella; Santoni, Angela; Porcellini, Antonio.

In: Biochemical and Biophysical Research Communications, Vol. 320, No. 2, 23.07.2004, p. 493-500.

Research output: Contribution to journalArticle

Messina, S, Leonetti, C, De Gregorio, G, Affatigato, V, Ragona, G, Frati, L, Zupi, G, Santoni, A & Porcellini, A 2004, 'Ras inhibition amplifies cisplatin sensitivity of human glioblastoma', Biochemical and Biophysical Research Communications, vol. 320, no. 2, pp. 493-500. https://doi.org/10.1016/j.bbrc.2004.06.003
Messina, Samantha ; Leonetti, Carlo ; De Gregorio, Giorgia ; Affatigato, Valentina ; Ragona, Giuseppe ; Frati, Luigi ; Zupi, Gabriella ; Santoni, Angela ; Porcellini, Antonio. / Ras inhibition amplifies cisplatin sensitivity of human glioblastoma. In: Biochemical and Biophysical Research Communications. 2004 ; Vol. 320, No. 2. pp. 493-500.
@article{cca5bff04ef24c88990fe4c4df09a5c5,
title = "Ras inhibition amplifies cisplatin sensitivity of human glioblastoma",
abstract = "Resistance to chemotherapy is a common feature of malignant gliomas. This resistance is mediated by receptor tyrosine kinase (RTK)-regulated signaling. p21-Ras protein is pivotal in the propagation of the signal originated from many RTKs. Our aim was to investigate whether inhibition of Ras pathway affects the response to cisplatin in malignant gliomas. We found an enhanced sensitivity to cisplatin of two glioblastoma cell lines expressing dominant negative Ras. Moreover, DN-Ras expressing cells, implanted in nude mice, resulted in being extremely sensitive to cisplatin. The growth of all the tumors was significantly inhibited by combining DN-Ras adenovirus infection with cisplatin treatment. The majority of glioma cells expressing DN-Ras underwent apoptosis in response to cisplatin. In vivo, DN-Ras alone did not influence the growth of tumors, suggesting that the effects of Ras-inhibition observed in vitro could not be extrapolated in vivo. The survival signal pathway transduced by Ras was essentially mediated by inhibition of caspase-9 cleavage via PI3K/Akt.",
keywords = "Apoptosis, Chemotherapy, Drug resistance, Gene therapy, Glioblastoma, Ras, Signal transduction",
author = "Samantha Messina and Carlo Leonetti and {De Gregorio}, Giorgia and Valentina Affatigato and Giuseppe Ragona and Luigi Frati and Gabriella Zupi and Angela Santoni and Antonio Porcellini",
year = "2004",
month = "7",
day = "23",
doi = "10.1016/j.bbrc.2004.06.003",
language = "English",
volume = "320",
pages = "493--500",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Ras inhibition amplifies cisplatin sensitivity of human glioblastoma

AU - Messina, Samantha

AU - Leonetti, Carlo

AU - De Gregorio, Giorgia

AU - Affatigato, Valentina

AU - Ragona, Giuseppe

AU - Frati, Luigi

AU - Zupi, Gabriella

AU - Santoni, Angela

AU - Porcellini, Antonio

PY - 2004/7/23

Y1 - 2004/7/23

N2 - Resistance to chemotherapy is a common feature of malignant gliomas. This resistance is mediated by receptor tyrosine kinase (RTK)-regulated signaling. p21-Ras protein is pivotal in the propagation of the signal originated from many RTKs. Our aim was to investigate whether inhibition of Ras pathway affects the response to cisplatin in malignant gliomas. We found an enhanced sensitivity to cisplatin of two glioblastoma cell lines expressing dominant negative Ras. Moreover, DN-Ras expressing cells, implanted in nude mice, resulted in being extremely sensitive to cisplatin. The growth of all the tumors was significantly inhibited by combining DN-Ras adenovirus infection with cisplatin treatment. The majority of glioma cells expressing DN-Ras underwent apoptosis in response to cisplatin. In vivo, DN-Ras alone did not influence the growth of tumors, suggesting that the effects of Ras-inhibition observed in vitro could not be extrapolated in vivo. The survival signal pathway transduced by Ras was essentially mediated by inhibition of caspase-9 cleavage via PI3K/Akt.

AB - Resistance to chemotherapy is a common feature of malignant gliomas. This resistance is mediated by receptor tyrosine kinase (RTK)-regulated signaling. p21-Ras protein is pivotal in the propagation of the signal originated from many RTKs. Our aim was to investigate whether inhibition of Ras pathway affects the response to cisplatin in malignant gliomas. We found an enhanced sensitivity to cisplatin of two glioblastoma cell lines expressing dominant negative Ras. Moreover, DN-Ras expressing cells, implanted in nude mice, resulted in being extremely sensitive to cisplatin. The growth of all the tumors was significantly inhibited by combining DN-Ras adenovirus infection with cisplatin treatment. The majority of glioma cells expressing DN-Ras underwent apoptosis in response to cisplatin. In vivo, DN-Ras alone did not influence the growth of tumors, suggesting that the effects of Ras-inhibition observed in vitro could not be extrapolated in vivo. The survival signal pathway transduced by Ras was essentially mediated by inhibition of caspase-9 cleavage via PI3K/Akt.

KW - Apoptosis

KW - Chemotherapy

KW - Drug resistance

KW - Gene therapy

KW - Glioblastoma

KW - Ras

KW - Signal transduction

UR - http://www.scopus.com/inward/record.url?scp=2942711576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942711576&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2004.06.003

DO - 10.1016/j.bbrc.2004.06.003

M3 - Article

C2 - 15219856

AN - SCOPUS:2942711576

VL - 320

SP - 493

EP - 500

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -